University of Texas's MD Anderson Cancer Center: Study Identifies Gut Microbes Associated With Toxicity to Combined Checkpoint Inhibitors in Melanoma Patients
July 09, 2021
July 09, 2021
HOUSTON, Texas, July 9 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
Researchers from The University of Texas MD Anderson Cancer Center found specific intestinal microbiota signatures correlate with high-grade adverse events and response to combined CTLA-4 and PD-1 blockade treatment. The study, published today in Nature Medicine, also identified a potential new strategy to treat toxicity - while maintaining response - to com . . .
Researchers from The University of Texas MD Anderson Cancer Center found specific intestinal microbiota signatures correlate with high-grade adverse events and response to combined CTLA-4 and PD-1 blockade treatment. The study, published today in Nature Medicine, also identified a potential new strategy to treat toxicity - while maintaining response - to com . . .